Hims, a health company, had some big news! They make weight-loss medicine, and their recent earnings were amazing – up 1000%! But their stock price dropped a lot after that. Let's find out why!
- Hims sells a medicine similar to Ozempic and Wegovy, popular weight-loss drugs.
- The FDA (Food and Drug Administration) said Hims can't make as much of this medicine anymore.
- Hims plans to sell a slightly different version, but investors were worried.
- Hims stock went down over 24% in one day!
| Fact | Number |
|---|---|
| Hims' stock price drop | 24%+ |
| Hims' earnings growth | 1000% |
| Hims' sales growth | 95%+ |
| Hims' expected 2024 sales | $2.3 - $2.4 Billion |
